Skip to main content

Modulation of Ligand Binding Affinity of Tumorigenic Carbonic Anhydrase XII Upon Interaction with Cationic CdTe Quantum Dots

Buy Article:

$113.00 plus tax (Refund Policy)

Abstract:

The structural data of tumorigenic carbonic anhydrase (CA) XII revealed that the enzyme surface opposite to the active site pocket was negatively charged, and thus it had potential to interact with the positively charged surfaces. We investigated the influence of cationic CdTe quantum dots on the catalytic and ligand binding properties of the enzyme. Although cationic quantum dots interacted with CAXII (with a Kd value of 2.1 M), they did not impair the enzyme's catalytic activity, suggesting that the accessibility of the enzyme's active site remained unaffected by the above interaction. When CAXII bound dansylamide (serving as a fluorescence probe as well as a potent inhibitor of the enzyme) was titrated with cationic quantum dots, the fluorescence spectral profiles revealed a marked transfer of the excited state energy between the above species. However, the binding of quantum dots to CAXII weakened the affinity of dansylamide for the enzyme, and thus obviated the inhibitory feature of the ligand. Since the quantum dots and dansylamide are bound at the opposite sides of CAXII, their influence must be mediated via changes in the protein conformation at a distal region as observed with allosteric enzymes. The mechanistic insights gained from these studies may lead toward developing diagnostic protocols for tumorigenic CAXII.

Keywords: CARBONIC ANHYDRASE; CDTE QUANTUM DOTS; ENERGY TRANSFER; FLUORESCENCE SPECTROSCOPY; TUMOR

Document Type: Research Article

DOI: http://dx.doi.org/10.1166/jbn.2008.009

Publication date: December 1, 2008

More about this publication?
  • Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Partial Open Access Content
Partial Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more